{"id":"https://openalex.org/W2017582897","doi":"https://doi.org/10.1007/s40262-013-0100-7","title":"Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban","display_name":"Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban","publication_year":2013,"publication_date":"2013-09-02","ids":{"openalex":"https://openalex.org/W2017582897","doi":"https://doi.org/10.1007/s40262-013-0100-7","mag":"2017582897","pmid":"https://pubmed.ncbi.nlm.nih.gov/23999929","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3889701"},"language":"en","primary_location":{"id":"doi:10.1007/s40262-013-0100-7","doi":"https://doi.org/10.1007/s40262-013-0100-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-013-0100-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-013-0100-7.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s40262-013-0100-7.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110262004","display_name":"Wolfgang Mueck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Wolfgang Mueck","raw_affiliation_strings":["Clinical Pharmacology, Bayer Pharma AG, Aprather Weg 18a, 42113, Wuppertal, Germany, wolfgang.mueck@bayer.com","Clinical Pharmacology, Bayer Pharma AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Bayer Pharma AG, Aprather Weg 18a, 42113, Wuppertal, Germany, wolfgang.mueck@bayer.com","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Clinical Pharmacology, Bayer Pharma AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009387193","display_name":"Jan Julius Stampfuss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jan Stampfuss","raw_affiliation_strings":["Clinical Pharmacology, Bayer Pharma AG, Aprather Weg 18a, 42113, Wuppertal, Germany","Clinical Pharmacology, Bayer Pharma AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Bayer Pharma AG, Aprather Weg 18a, 42113, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Clinical Pharmacology, Bayer Pharma AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040870075","display_name":"Dagmar Kubitza","orcid":"https://orcid.org/0000-0001-8450-473X","observed_orcids":["https://orcid.org/0000-0001-8450-473X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dagmar Kubitza","raw_affiliation_strings":["Clinical Pharmacology, Bayer Pharma AG, Aprather Weg 18a, 42113, Wuppertal, Germany","Clinical Pharmacology, Bayer Pharma AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Bayer Pharma AG, Aprather Weg 18a, 42113, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"Clinical Pharmacology, Bayer Pharma AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085514176","display_name":"Michael Becka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael Becka","raw_affiliation_strings":["Department of Biometry, Pharmacometry, Bayer Pharma AG, Wuppertal, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biometry, Pharmacometry, Bayer Pharma AG, Wuppertal, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110262004"],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":{"value":4990,"currency":"USD","value_usd":4990},"fwci":5.1967,"has_fulltext":true,"cited_by_count":631,"citation_normalized_percentile":{"value":0.98084291,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"53","issue":"1","first_page":"1","last_page":"16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.1988999992609024,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.027699999511241913,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivaroxaban","display_name":"rivaroxaban","score":1.0},{"id":"https://openalex.org/keywords/direct-factor-xa-inhibitors","display_name":"direct factor Xa inhibitors","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8450000286102295},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9409999847412109},{"id":"https://openalex.org/keywords/food-effect","display_name":"food effect","score":0.4729999899864197},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.8009999990463257},{"id":"https://openalex.org/keywords/emax-model","display_name":"Emax model","score":0.7570000290870667},{"id":"https://openalex.org/keywords/prolonged-prothrombin-time","display_name":"prothrombin time prolongation","score":0.9279999732971191},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7310000061988831},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.8730000257492065},{"id":"https://openalex.org/keywords/thromboembolic-disorders","display_name":"thromboembolic disorders","score":0.8009999990463257},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.9929358959197998},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8054473996162415},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8028393387794495},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6562937498092651},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5997877717018127},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5370691418647766},{"id":"https://openalex.org/C2780434524","wikidata":"https://www.wikidata.org/wiki/Q1144385","display_name":"Prothrombin time","level":2,"score":0.4100012481212616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28823673725128174},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.2588355541229248},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.15523257851600647}],"mesh":[{"descriptor_ui":"D000069552","descriptor_name":"Rivaroxaban","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009025","descriptor_name":"Morpholines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1007/s40262-013-0100-7","doi":"https://doi.org/10.1007/s40262-013-0100-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-013-0100-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-013-0100-7.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2876992","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3889701","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3889701","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3889701","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacokinet","raw_type":"Text"},{"id":"pmid:23999929","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23999929","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacokinetics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.783.1148","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.783.1148","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/34/e8/40262_2013_Article_100.PMC3889701.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s40262-013-0100-7","doi":"https://doi.org/10.1007/s40262-013-0100-7","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40262-013-0100-7","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40262-013-0100-7.pdf","source":{"id":"https://openalex.org/S69290020","display_name":"Clinical Pharmacokinetics","issn_l":"0312-5963","issn":["0312-5963","1179-1926"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacokinetics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320317188","display_name":"Janssen Scientific Affairs","ror":"https://ror.org/04w4xsz15"},{"id":"https://openalex.org/F4320320303","display_name":"Bayer HealthCare","ror":"https://ror.org/04hmn8g73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017582897.pdf","grobid_xml":"https://content.openalex.org/works/W2017582897.grobid-xml"},"referenced_works_count":70,"referenced_works":["https://openalex.org/W43308025","https://openalex.org/W1480212256","https://openalex.org/W1485772655","https://openalex.org/W1564607482","https://openalex.org/W1577484948","https://openalex.org/W1603429979","https://openalex.org/W1812338265","https://openalex.org/W1965492206","https://openalex.org/W1968841012","https://openalex.org/W1969218311","https://openalex.org/W1971011626","https://openalex.org/W1974029170","https://openalex.org/W1979251728","https://openalex.org/W1980298414","https://openalex.org/W1981633543","https://openalex.org/W1984935828","https://openalex.org/W1989930316","https://openalex.org/W1998354077","https://openalex.org/W2007969584","https://openalex.org/W2014491911","https://openalex.org/W2014616799","https://openalex.org/W2019960723","https://openalex.org/W2020477844","https://openalex.org/W2021621876","https://openalex.org/W2028162842","https://openalex.org/W2028718651","https://openalex.org/W2036007875","https://openalex.org/W2036506340","https://openalex.org/W2039706957","https://openalex.org/W2045987573","https://openalex.org/W2049526508","https://openalex.org/W2060578439","https://openalex.org/W2064627639","https://openalex.org/W2064826963","https://openalex.org/W2069707383","https://openalex.org/W2074222120","https://openalex.org/W2074947904","https://openalex.org/W2075341962","https://openalex.org/W2083713858","https://openalex.org/W2086443301","https://openalex.org/W2097854437","https://openalex.org/W2103196751","https://openalex.org/W2103573619","https://openalex.org/W2113469166","https://openalex.org/W2115787552","https://openalex.org/W2116930113","https://openalex.org/W2117677020","https://openalex.org/W2119622751","https://openalex.org/W2120108153","https://openalex.org/W2120794058","https://openalex.org/W2123448465","https://openalex.org/W2127090290","https://openalex.org/W2130199362","https://openalex.org/W2130530183","https://openalex.org/W2135700027","https://openalex.org/W2137477398","https://openalex.org/W2148984742","https://openalex.org/W2149157540","https://openalex.org/W2150567120","https://openalex.org/W2151252098","https://openalex.org/W2153438515","https://openalex.org/W2157089195","https://openalex.org/W2157224841","https://openalex.org/W2159407715","https://openalex.org/W2167182965","https://openalex.org/W2167399732","https://openalex.org/W2481569543","https://openalex.org/W2558370843","https://openalex.org/W4236825038","https://openalex.org/W4292004352"],"related_works":["https://openalex.org/W7100146066","https://openalex.org/W1786021016","https://openalex.org/W2052190924","https://openalex.org/W1989930316","https://openalex.org/W2615293208","https://openalex.org/W2000407236","https://openalex.org/W1969218311","https://openalex.org/W2039706957","https://openalex.org/W2149157540","https://openalex.org/W1965492206"],"abstract_inverted_index":{"Rivaroxaban":[0,120,160,190],"is":[1,23,39,70,82,126],"an":[2,148],"oral,":[3],"direct":[4],"Factor":[5,13,16,141],"Xa":[6,14,17,142],"inhibitor":[7],"that":[8,125],"targets":[9],"free":[10],"and":[11,15,52,57,87,114,135,152],"clot-bound":[12],"in":[18,66,84,110,117,197],"the":[19,44,54,67],"prothrombinase":[20],"complex.":[21],"It":[22],"absorbed":[24],"rapidly,":[25],"with":[26,63,103,129,185],"maximum":[27],"plasma":[28,101,131],"concentrations":[29],"being":[30],"reached":[31],"2-4":[32],"h":[33,109,116],"after":[34],"tablet":[35,47],"intake.":[36],"Oral":[37],"bioavailability":[38],"high":[40],"(80-100":[41],"%)":[42],"for":[43,53,138,194],"10":[45],"mg":[46,56,59],"irrespective":[48],"of":[49,73,80,92,98,107,140],"food":[50],"intake":[51],"15":[55],"20":[58],"tablets":[60],"when":[61],"taken":[62],"food.":[64],"Variability":[65],"pharmacokinetic":[68,78,134],"parameters":[69],"moderate":[71],"(coefficient":[72],"variation":[74],"30-40":[75],"%).":[76],"The":[77,133],"profile":[79],"rivaroxaban":[81,99,174],"consistent":[83],"healthy":[85,111],"subjects":[86,113],"across":[88],"a":[89,104,122,157],"broad":[90],"range":[91],"different":[93],"patient":[94],"populations":[95],"studied.":[96],"Elimination":[97],"from":[100],"occurs":[102],"terminal":[105],"half-life":[106],"5-9":[108],"young":[112],"11-13":[115],"elderly":[118],"subjects.":[119],"produces":[121],"pharmacodynamic":[123,136],"effect":[124],"closely":[127],"correlated":[128],"its":[130],"concentration.":[132],"relationship":[137],"inhibition":[139],"activity":[143],"can":[144],"be":[145],"described":[146],"by":[147,156],"E":[149],"max":[150],"model,":[151],"prothrombin":[153],"time":[154],"prolongation":[155],"linear":[158],"model.":[159],"does":[161],"not":[162],"inhibit":[163],"cytochrome":[164],"P450":[165],"enzymes":[166],"or":[167],"known":[168],"drug":[169],"transporter":[170],"systems":[171],"and,":[172],"because":[173],"has":[175,180,191],"multiple":[176],"elimination":[177],"pathways,":[178],"it":[179],"no":[181],"clinically":[182],"relevant":[183],"interactions":[184],"most":[186],"commonly":[187],"prescribed":[188],"medications.":[189],"been":[192],"approved":[193],"clinical":[195],"use":[196],"several":[198],"thromboembolic":[199],"disorders.":[200]},"counts_by_year":[{"year":2026,"cited_by_count":58},{"year":2025,"cited_by_count":66},{"year":2024,"cited_by_count":60},{"year":2023,"cited_by_count":57},{"year":2022,"cited_by_count":72},{"year":2021,"cited_by_count":50},{"year":2020,"cited_by_count":47},{"year":2019,"cited_by_count":47},{"year":2018,"cited_by_count":52},{"year":2017,"cited_by_count":37},{"year":2016,"cited_by_count":37},{"year":2015,"cited_by_count":30},{"year":2014,"cited_by_count":16},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}